Clinical Trials Directory

Trials / Completed

CompletedNCT03626116

Patient Satisfaction After Silicone Metacarpophalangeal Arthroplasty

What Determines Satisfaction of Patients With Rheumatoid Arthritis After Hand Reconstruction Using Silicone Metacarpophalangeal Arthroplasty

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Schulthess Klinik · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to identify determinants of long-term patient satisfaction after hand reconstruction using silicone metacarpophalangeal arthroplasty (SMPA). The investigators hypothesize that appearance of the hand, ulnar drift, range of motion, pain, hand function and intake of the newer antirheumatic drugs (i.e. biologicals) influence patient satisfaction.

Detailed description

This is an ambidirectional, monocenter research project consisting of a retrospective chart review and a prospective cohort project. Participants fulfilling all of the following inclusion criteria are eligible for the project: * Patients with rheumatoid Arthritis (RA) / Psoriasisarthritis / Lupus erythomatodes who had a SMPA between Jan 2007 and one year before the project examination * Informed Consent as documented by signature The presence of any one of the following exclusion criteria will lead to exclusion of the participant: * Major surgery at another joint at the hand (e.g. proximal interphalangeal (PIP) joint arthroplasty, thumb trapeziectomy) less than 6 months ago * Legal incompetence * German language barrier to complete the questionnaires

Conditions

Interventions

TypeNameDescription
PROCEDUREsilicone metacarpophalangeal arthroplasty (SMPA)Replacement of the metacarpophalangeal (MCP) joint using a silicone arthroplasty

Timeline

Start date
2018-07-18
Primary completion
2018-12-19
Completion
2018-12-19
First posted
2018-08-10
Last updated
2019-04-05

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03626116. Inclusion in this directory is not an endorsement.